Published in J Biol Chem on August 05, 1992
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med (2003) 3.61
Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A (1999) 2.98
Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci U S A (2006) 2.65
Tissue factor activation: is disulfide bond switching a regulatory mechanism? Blood (2007) 2.37
Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium. J Biol Chem (2007) 2.01
Cystine 186-cystine 209 disulfide bond is not essential for the procoagulant activity of tissue factor or for its de-encryption. Blood (2010) 1.92
Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood (2004) 1.80
Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol (1996) 1.41
Extracellular protein disulfide isomerase regulates coagulation on endothelial cells through modulation of phosphatidylserine exposure. Blood (2010) 1.29
Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation. Thromb Haemost (2014) 1.29
Endothelial cell protein C receptor cellular localization and trafficking: potential functional implications. Blood (2009) 1.28
Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol. Blood (2004) 1.27
Cellular localization and trafficking of tissue factor. Blood (2006) 1.23
Tissue factor expression in human arterial smooth muscle cells. TF is present in three cellular pools after growth factor stimulation. J Clin Invest (1997) 1.18
Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability. Arterioscler Thromb Vasc Biol (2005) 1.14
Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase. Blood (2013) 1.07
Regulation of tissue factor coagulant activity on cell surfaces. J Thromb Haemost (2012) 0.99
Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling. Blood (2007) 0.97
Tissue factor encryption and decryption: facts and controversies. Thromb Res (2012) 0.96
Therapeutic implications of protein disulfide isomerase inhibition in thrombotic disease. Arterioscler Thromb Vasc Biol (2014) 0.94
Factor VIIa binding and internalization in hepatocytes. J Thromb Haemost (2005) 0.90
Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy. Int J Clin Exp Med (2009) 0.90
Plasmin enhances cell surface tissue factor activity in mesothelial and endothelial cells. J Thromb Haemost (2008) 0.86
Role of PDI in regulating tissue factor: FVIIa activity. Thromb Res (2010) 0.86
Tissue factor: mechanisms of decryption. Front Biosci (Elite Ed) (2012) 0.85
Tissue factor mutated at the allosteric Cys186-Cys209 disulfide bond is severely impaired in decrypted procoagulant activity. Blood (2010) 0.84
Cryptic messages: is noncoagulant tissue factor reserved for cell signaling? Proc Natl Acad Sci U S A (2006) 0.83
Tissue Factor-Factor VII Complex As a Key Regulator of Ovarian Cancer Phenotypes. Biomark Cancer (2015) 0.82
Role of thiol pathways in TF procoagulant regulation. Thromb Res (2012) 0.82
Role of tissue factor disulfides and lipid rafts in signaling. Thromb Res (2008) 0.81
Analysis of factor VIIa binding to relipidated tissue factor by surface plasmon resonance. Blood Coagul Fibrinolysis (2010) 0.81
Analysis of tissue factor expression in various cell model systems: cryptic vs. active. J Thromb Haemost (2013) 0.80
The Role of Putative Phosphatidylserine-Interactive Residues of Tissue Factor on Its Coagulant Activity at the Cell Surface. PLoS One (2016) 0.75
Evaluation of procoagulant tissue factor expression in canine hemangiosarcoma cell lines. Am J Vet Res (2017) 0.75
Factor VIIa interaction with tissue factor and endothelial cell protein C receptor on cell surfaces. Semin Hematol (2008) 0.75
Thrombosis in patients with the lupus anticoagulant. Ann Intern Med (1980) 4.02
Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A (1977) 2.79
The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood (1969) 2.61
Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med (1984) 2.26
Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res (1990) 1.90
Intravascular coagulation in fulminant meningococcemia. Ann Intern Med (1967) 1.86
Coumarin necrosis associated with hereditary protein C deficiency. Ann Intern Med (1984) 1.78
Immunohistochemical identification of tissue factor in solid tumors. Cancer (1992) 1.77
Acquired inhibitors of blood coagulation. Prog Hemost Thromb (1972) 1.74
The tissue factor pathway: how it has become a "prima ballerina". Thromb Haemost (1995) 1.72
Studies of the activation of factor VII bound to tissue factor. Blood (1996) 1.62
Synthesis of intrinsic factor X activator. Inhibition of the function of formed activator by antibodies to factor VIII and to factor IX. Biochemistry (1970) 1.62
Induction of tissue factor expression in whole blood: lack of evidence for the presence of tissue factor expression in granulocytes. Thromb Haemost (2000) 1.58
Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator. Blood (1977) 1.50
A plasma protein C activity assay suitable for a clinical laboratory. Its use to measure activity in hereditary and acquired deficiency states. Am J Clin Pathol (1987) 1.44
Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol (1996) 1.41
A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem (1981) 1.40
Bleeding time after aspirin in disorders of intrinsic clotting. N Engl J Med (1969) 1.40
Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery. J Clin Invest (1979) 1.37
Isolation and characterization of human factor VII. Activation of factor VII by factor Xa. J Biol Chem (1981) 1.37
Hemophilia A: polymorphism detectable by a factor 8 antibody. Science (1969) 1.32
Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor. J Biol Chem (1997) 1.32
Anti-prothrombin antibodies and the lupus anticoagulant. Blood (1988) 1.22
Hemophilia B: characterization of genetic variants and detection of carriers. Blood (1977) 1.20
Trousseau's syndrome. West J Med (1993) 1.19
Defibrination after brain-tissue destruction: A serious complication of head injury. N Engl J Med (1974) 1.17
Hemophilia prophylaxis with factor VIII concentrate. Arch Intern Med (1970) 1.16
Formation of intrinsic factor-X activator activity, with special reference to the role of thrombin. Br J Haematol (1971) 1.16
Studies of the mechanism for enhanced cell surface factor VIIa/tissue factor activation of factor X on fibroblast monolayers after their exposure to N-ethylmaleimide. Thromb Haemost (1994) 1.15
Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation. Proc Natl Acad Sci U S A (1988) 1.15
The blood clotting properties of rabbit peritoneal leukocytes in vitro. Thromb Diath Haemorrh (1967) 1.15
Novel mutation method for increased cellulase production. J Appl Microbiol (2005) 1.13
Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component. Blood (1985) 1.13
Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb (1992) 1.11
Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol Reprod (1995) 1.11
Albinism and abnormal platelet function. N Engl J Med (1971) 1.08
Developmental expression and cellular localization of glucose transporter molecules during mouse preimplantation development. Development (1992) 1.08
Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant. Proc Natl Acad Sci U S A (1991) 1.07
Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. Blood (1979) 1.07
Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. Blood (1987) 1.05
Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII. J Clin Invest (1979) 1.04
Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin. Suppression of activation of transcription factors Egr-1, AP-1, and NF-kappa B. Arterioscler Thromb Vasc Biol (1997) 1.03
The basalis of the primate endometrium: a bifunctional germinal compartment. Biol Reprod (1989) 1.03
Endotoxin-induced intravascular clotting: the need for granulocytes. Thromb Diath Haemorrh (1968) 1.02
Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain. J Biol Chem (1999) 1.02
Separation from Russell's viper venom of one fraction reacting with factor X and another reacting with factor V. Biochemistry (1969) 1.02
Preimplantation mouse embryos internalize maternal insulin via receptor-mediated endocytosis: pattern of uptake and functional correlations. Dev Biol (1989) 1.00
A monoclonal antibody to factor IX that inhibits the factor VIII:Ca potentiation of factor X activation. J Biol Chem (1985) 0.98
Consumption of serum factors and prothrombin during intravascular clotting in rabbits. Scand J Haematol (1966) 0.97
The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation. Thromb Haemost (1991) 0.97
A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood (1983) 0.96
Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells : A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine. Arterioscler Thromb Vasc Biol (1999) 0.96
Acidic and basic fibroblast growth factors suppress transcriptional activation of tissue factor and other inflammatory genes in endothelial cells. Arterioscler Thromb Vasc Biol (1997) 0.96
Mechanisms of binding of recombinant extrinsic pathway inhibitor (rEPI) to cultured cell surfaces. Evidence that rEPI can bind to and inhibit factor VIIa-tissue factor complexes in the absence of factor Xa. J Biol Chem (1992) 0.96
Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors. J Clin Invest (1993) 0.95
A procedure for isolation of human protein C and protein S as by-products of the purification of factors VII, IX, X and prothrombin. Prep Biochem (1983) 0.95
Binding of factor VIIa to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa. Blood (1993) 0.95
Purification of human factor VII utilizing O-(diethylaminoethyl)-Sephadex and Sulfopropyl-Sephadex chromatography. Anal Biochem (1984) 0.95
Factor V anticoagulants: clinical, biochemical, and immunological observations. J Clin Invest (1970) 0.94
Hemostatic factors in rabbit limb lymph: relationship to mechanisms regulating extravascular coagulation. Am J Physiol (1998) 0.94
Active site blockade of factor VIIa alters its intracellular distribution. J Biol Chem (2001) 0.93
Correction of excessive anticoagulation with low-dose oral vitamin K1. Ann Intern Med (1997) 0.93
Thrombotic thrombocytopenic purpura. Serial clotting studies, relation to the generalized Shwartzman reaction, and remission after adrenal steroid and dextran therapy. Ann Intern Med (1967) 0.93
Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol (2000) 0.92
Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction. Blood (1991) 0.91
Effects of thorium dioxide upon blood clotting and platelets. I. In vitro studies. Thromb Diath Haemorrh (1966) 0.91
Enhancement by human umbilical vein endothelial cells of factor Xa-catalyzed activation of factor VII. Blood (1988) 0.91
Activation of human factor VII by activated factors IX and X. Blood (1982) 0.90
An acquired inhibitor of fibrin stabilization associated with isoniazid therapy: clinical and biochemical observations. Blood (1974) 0.89
Binding of factor VIIa to tissue factor induces alterations in gene expression in human fibroblast cells: up-regulation of poly(A) polymerase. Proc Natl Acad Sci U S A (1997) 0.89
Regulation of tissue factor pathway inhibitor expression in smooth muscle cells. Blood (1999) 0.89
Activation of human factor VII in the initiation of tissue factor-dependent coagulation. Blood (1986) 0.89
Radioimmunoassays for protein C and factor X. Plasma antigen levels in abnormal hemostatic states. Am J Clin Pathol (1984) 0.87
The plasma protamine paracoagulation test: clinical and laboratory evaluation. Am J Clin Pathol (1972) 0.87
Symptomatic human rotavirus subgroups, serotypes & electropherotypes in Hyderabad, India. Indian J Med Res (2000) 0.87
Platelets and initiation of intrinsic clotting. Br J Haematol (1973) 0.87
Suppression of transcription factor Egr-1 by curcumin. Thromb Res (2000) 0.87
Functional and binding studies of the roles of prothrombin and beta 2-glycoprotein I in the expression of lupus anticoagulant activity. Blood (1994) 0.87
Activation of 125I-factor IX and 125I-factor X: effect of tissue factor and factor VII, factor Xa and thrombin. Scand J Haematol (1980) 0.87
Further evidence that thrombin-activation of Factor 8 is an essential step in intrinsic clotting. Scand J Clin Lab Invest (1965) 0.86
Mechanism for diminished tissue factor expression by endothelial cells cultured with heparin binding growth factor-1 and heparin. Blood (1991) 0.86
Antibody response and characteristics of antibodies in women immunized with three contraceptive vaccines inducing antibodies against human chorionic gonadotropin. Fertil Steril (1989) 0.86
Factor VIIa-catalyzed activation of factor X independent of tissue factor: its possible significance for control of hemophilic bleeding by infused factor VIIa. Blood (1990) 0.86
Intravascular clotting after endotoxin in rabbits with impaired intrinsic clotting produced by a factor VIII antibody. Blood (1973) 0.86
Discordant expression of tissue factor and its activity in polarized epithelial cells. Asymmetry in anionic phospholipid availability as a possible explanation. Blood (1999) 0.85